|
시장보고서
상품코드
2106660
지속적 신대체요법(CRRT) 장치 : 시장 인사이트, 경쟁 구도 및 시장 예측(-2034년)Continuous Renal Replacement Therapy (CRRT) Machines - Market Insights, Competitive Landscape, and Market Forecast - 2034 |
||||||
DelveInsight
개요:
- 지속적 신장 대체 요법(CRRT) 장치 시장은 2025년에 12억 5,000만 달러로 추정되며, 2034년까지 25억 2,000만 달러에 달할 것으로 예측됩니다. 이러한 성장의 배경에는 중증 환자에서 발생하는 급성 신장 손상(AKI) 및 패혈증의 전 세계적 부담 증가, 중환자실(ICU) 인프라 확충, 그리고 자동화 및 AI 기반 CRRT 플랫폼의 지속적인 기술 발전이 있습니다.
- 전 세계 CRRT 장치 시장은 2026년부터 2034년까지의 예측 기간 동안 연평균 성장률(CAGR) 8.20%로 성장하고 있습니다.
- 제품 유형별로는 2025년에 장비 부문이 54%의 점유율을 차지하며 CRRT 장비 시장을 주도했습니다.
- 모달리티별로는 2025년에 연속 정맥-정맥 혈액투석여과(CVVHDF) 부문이 38%의 점유율을 차지하며 CRRT 장비 시장을 주도했습니다.
- 환자 유형별로는 2025년에 성인 부문이 CRRT 기기 시장에서 78%의 점유율을 차지하며 시장을 주도했습니다.
- 최종 사용자별로는 2025년에 병원 부문이 CRRT 기기 시장에서 65%의 점유율을 차지하며 시장을 주도했습니다.
- 2025년, 북미는 전 세계 CRRT 기기 시장 매출에서 40%의 점유율을 차지하며, 전 세계적으로 가장 높은 지역별 시장 점유율을 기록했습니다.
지속적 신장 대체 요법(CRRT) 장치는 기존의 간헐적인 혈액 투석과 달리, 급성 신장 손상이나 다기관 부전을 동반하여 혈역학이 불안정한 중증 환자를 대상으로 완만하고 지속적인 혈액 정화를 수행하는 특수한 중환자 치료용 의료기기입니다. CRRT 장치는 체외 순환 회로와 헤모필터를 통해 혈액을 순환시켜, 24시간 주기로 용질, 과잉 체액, 전해질을 서서히 제거하는 동시에 급격한 혈역학적 변화를 최소화합니다. 또한 필터, 카테터, 투석액, 치환액 등의 전용 소모품에 의해 지원됩니다. 중환자실(ICU)에 입원해 있는 중증 환자는 표준 투석에 수반되는 급격한 체액량 및 용질의 변동을 견디지 못하는 경우가 많기 때문에 CRRT는 중환자 치료 환경에서 신장 기능 지원을 위한 표준 치료법으로 자리 잡고 있습니다. 시장은 제품 유형별(장치 및 소모품), 치료법별(저속 연속 한외여과(SCUF), 연속 정맥-정맥 혈액여과(CVVH), 연속 정맥-정맥 혈액투석(CVVHD), 연속 정맥-정맥 혈액투석여과(CVVHDF)), 환자별(성인 및 소아), 최종 사용자별(병원, 투석 센터, 기타)로 분류됩니다. 전 세계적으로 급성 신장 손상 및 패혈증 발생률 증가, 중환자실(ICU) 수용 능력 확대, 고령자 및 중증 환자 수 증가, 그리고 자동화·AI 탑재·휴대형 CRRT 플랫폼 분야의 지속적인 기술 혁신에 힘입어, CRRT 장치는 전 세계 중환자 치료에서 신장 기능 지원을 뒷받침하는 필수적인 인프라로 자리매김하고 있습니다.
지속적 신대체 요법(CRRT) 장치 시장의 주요 시장 성장 촉진요인
- 전 세계적으로 증가하고 있는 급성 신장 손상(AKI) 발생률이 수요를 견인하고 있으며, 국제신장학회(ISN)의 추정에 따르면 전 세계적으로 연간 약 1,330만 건의 AKI가 발생하고 있으며, 그중 약 1,130만 건이 신흥 경제국에 집중되어 있습니다.
- 세계 패혈증 연합(Global Sepsis Alliance)에 따르면, 매년 약 4,700만-5,000만 명이 앓고 있는 것으로 추정되는 패혈증의 전 세계 높은 유병률은 중증 환자의 체액 균형을 관리하고 염증성 독소를 제거하기 위한 지속적 신장 대체 요법에 대한 수요를 확대시키고 있습니다.
- 중환자실(ICU) 수용 능력 확대와 중증 환자 입원율 상승에 따라, 지속적이고 혈역학적으로 허용 가능한 신장 대체 요법이 필요한 환자의 잠재적 대상층이 확대되고 있습니다.
- 자동 투여, 통합된 디지털 연결성, 간소화된 회로 설정 등을 포함한 지속적인 제품 개발과 차세대 플랫폼의 출시로 사용 편의성이 향상되고, ICU 전반에 걸쳐 장비 교체 주기가 촉진되고 있습니다.
- 전 세계적인 고령화와 당뇨병, 고혈압, 심혈관 질환 등의 동반 질환 유병률 증가로 인해, 급성기에 신장 지원이 필요한 급성 신장 손상 및 만성 신장 질환의 발생률이 증가하고 있습니다.
- AI를 통합하고 원격 모니터링이 가능한 CRRT 플랫폼의 도입 확대에 따라 치료 정확도가 향상되고 임상의의 부담이 경감될 뿐만 아니라, 중환자 치료 분야 전반에 걸친 분산형 및 휴대형 제공 모델이 지원되면서 신흥 경제국의 의료 인프라 확충이 진행되고 있습니다.
- AKI(급성 신장 손상) 및 패혈증의 부담 증가, ICU의 확대, 그리고 플랫폼의 지속적인 혁신이 맞물려 2034년까지 시장은 안정적인 한 자릿수 후반대의 성장을 유지할 것으로 예측됩니다.
지속적 신장 대체 요법(CRRT) 장치 시장의 성장에 기여하는 요인
시장 성장 촉진요인
세계 급성 신장 손상(AKI) 부담 증가
CRRT 장치 시장의 가장 근본적인 촉진요인은 중증 환자에서 급성 신장 손상의 발생률이 전 세계적으로 높은 수준을 유지하고 있다는 점입니다. 국제신장학회(ISN)의 추산에 따르면, 전 세계적으로 연간 약 1,330만 건의 급성 신장 손상(AKI)이 발생하고 있으며, 그 대부분은 신흥 경제국에 집중되어 있어 이들 국가에서는 연간 약 1,130만 건이 발생하는 것으로 추정됩니다. AKI는 패혈증, 대수술, 외상, 다기관 부전을 동반하는 경우가 많으며, 혈역학적으로 불안정한 환자는 기존의 간헐적 혈액투석에 수반되는 급격한 체액 및 용질 변동을 견디지 못하는 경우가 많습니다. CRRT는 체액 및 용질의 제거를 단계적이고 지속적으로 수행하기 때문에 이러한 상황에서 바람직한 신장 대체 요법이 됩니다. 또한, 중환자 치료 역량의 확대에 따라 AKI 발생률이 계속 상승하는 가운데, 2034년까지 CRRT 장비 및 관련 소모품에 대한 수요도 이에 따라 증가할 것으로 예측됩니다.
세계적으로 높은 패혈증 유병률
패혈증은 중환자실(ICU) 입원의 주요 원인이며, 지속적 신대체 요법의 주요 적응증이기도 합니다. 세계 패혈증 연합(World Sepsis Alliance)이 최근 업데이트한 추산에 따르면, 전 세계적으로 매년 4,700만 명에서 5,000만 명이 패혈증에 걸리고 있으며, 중증 패혈증이나 패혈성 쇼크에 수반되는 체액 과다, 전해질 이상, 염증성 독소 부하를 관리하기 위해 CRRT가 널리 활용되고 있습니다. 2012년 세계 패혈증 연합이 제창한 ‘세계 패혈증의 날’이 전 세계적으로 정착됨에 따라, 지속적 신장 대체 요법의 역할을 포함하여 패혈증 관리에 대한 임상 현장 및 일반 시민의 인식이 더욱 높아졌습니다. 전 세계적으로 패혈증 발생률은 여전히 높은 수준을 유지하고 있으며, 중환자실(ICU) 프로토콜에서도 혈역학적 안정화를 위해 CRRT가 점점 더 많이 도입되고 있는 만큼, 이러한 요인으로 인해 예측 기간 동안 장비 및 소모품에 대한 견조한 수요가 지속될 것으로 전망됩니다.
시장 제약 요인
꾸준한 성장세를 보이고 있음에도 불구하고, CRRT 기기 시장은 중대한 제약에 직면해 있습니다. CRRT 자체가 혈역학적 불안정, 체액 균형의 교란, 그리고 혈중 전해질 농도의 변화를 초래할 가능성이 있기 때문에 신중한 임상 관리와 숙련된 간호사 및 의사의 감독이 필요하며, 이는 자원이 제한된 환경에서 도입을 제한하는 요인이 될 수 있습니다. CRRT 장치의 높은 초기 투자 비용에 더해, 필터, 카테터, 투석액, 교체액, 항응고액 등의 전용 소모품에 대한 지속적인 비용은 신흥 경제국의 소규모 병원 및 의료 시스템에 있어 경제적 장벽이 되고 있습니다. 또한, 중환자실 간호 인력과 지속적 신장 지원 훈련을 받은 임상의의 부족도 도입 확대를 더욱 제약하고 있으며, 주요 시장의 엄격한 규제 준수 요건으로 인해 제품 개발 및 승인까지의 기간이 길어지고 있습니다. 또한, CRRT 시술에 대한 보험 환급 정책은 지역에 따라 크게 다르며, 확립된 장비 및 소모품 공급업체가 제한적이라는 점에 의존하고 있어 공급 위험이 집중되어 있습니다. 이러한 임상적, 자본적, 인적, 보험 환급상의 장벽이 복합적으로 작용하여, 급성 신장 손상(AKI) 및 패혈증의 부담 증가, 중환자실(ICU) 확대, 플랫폼 혁신과 같은 근본적인 촉진요인이 여전히 확고하게 존재함에도 불구하고 성장 속도는 둔화되고 있습니다.
자주 묻는 질문
목차
제1장 지속적 신대체요법(CRRT) 장치 시장 : 서론
제2장 지속적 신대체요법(CRRT) 장치 시장 : 주요 요약
제3장 지속적 신대체요법(CRRT) 장치 시장 : 주요 요인 분석
제4장 AI, 지정학, 무역 및 경제 동향
제5장 규제 분석
제6장 Porter의 Five Forces 분석
제7장 지속적 신대체요법(CRRT) 장치 시장 : 평가
제8장 지속적 신대체요법(CRRT) 장치 시장 : 경쟁 구도
제9장 지속적 신대체요법(CRRT) 장치 시장 : 스타트업의 자금조달 및 투자 동향
제10장 지속적 신대체요법(CRRT) 장치 시장 : 기업 개요 및 제품 개요
제11장 KOL(Key Opinion Leader)의 견해
제12장 프로젝트 접근
제13장 DelveInsight에 대해
제14장 면책사항 및 문의
LSH 26.08.12Continuous Renal Replacement Therapy (CRRT) Machines Market Summary
Overview:
- The Continuous Renal Replacement Therapy (CRRT) Machines market is estimated at USD 1.25 billion in 2025 and is projected to reach USD 2.52 billion by 2034. Growth is anchored in the rising global burden of acute kidney injury (AKI) and sepsis in critically ill patients, expanding intensive care unit (ICU) infrastructure, and continued technological advancement in automated, AI-enabled CRRT platforms.
- The global CRRT Machines market is growing at a CAGR of 8.20% during the forecast period from 2026 to 2034.
- By product type, the machines segment dominated the CRRT Machines market with a 54% share in 2025.
- By modality, the continuous venovenous hemodiafiltration (CVVHDF) segment dominated the CRRT Machines market with a 38% share in 2025.
- By patient, the adult segment dominated the CRRT Machines market with a 78% share in 2025.
- By end-user, the hospitals segment dominated the CRRT Machines market with a 65% share in 2025.
- North America dominated the global CRRT Machines market revenue with a 40% share in 2025, representing the highest regional market share globally.
A Continuous Renal Replacement Therapy (CRRT) machine is a specialized critical-care device that provides slow, continuous blood purification for hemodynamically unstable, critically ill patients with acute kidney injury or multi-organ failure, in contrast to conventional intermittent hemodialysis. CRRT machines circulate blood through an extracorporeal circuit and hemofilter, gradually removing solutes, excess fluid, and electrolytes over 24-hour cycles while minimizing rapid hemodynamic shifts, and are supported by dedicated consumables including filters, catheters, dialysates, and replacement solutions. Because critically ill patients in the ICU often cannot tolerate the rapid fluid and solute changes associated with standard dialysis, CRRT has become the standard of care for renal support in intensive care settings. The market is organized by product type across machines and consumables; by modality across slow continuous ultrafiltration (SCUF), continuous venovenous hemofiltration (CVVH), continuous venovenous hemodialysis (CVVHD), and continuous venovenous hemodiafiltration (CVVHDF); by patient across adult and pediatric populations; and by end-user across hospitals, dialysis centres, and others. Driven by the rising global incidence of acute kidney injury and sepsis, expanding ICU capacity, growing geriatric and critically ill patient populations, and continued innovation in automated, AI-enabled, and portable CRRT platforms, CRRT machines have become essential infrastructure underpinning critical-care renal support worldwide.
Continuous Renal Replacement Therapy (CRRT) Machines Market Key Growth Drivers
- The rising global incidence of acute kidney injury is driving demand, with the International Society of Nephrology estimating approximately 13.3 million cases of AKI annually worldwide, with a disproportionate burden of roughly 11.3 million cases in emerging economies.
- The high global prevalence of sepsis, affecting an estimated 47 to 50 million individuals each year according to the Global Sepsis Alliance, is expanding demand for continuous renal support to manage fluid balance and remove inflammatory toxins in critically ill patients.
- Expanding ICU capacity and rising hospital admission rates for critically ill patients are increasing the addressable base of patients requiring continuous, hemodynamically tolerable renal replacement therapy.
- Continued product development and next-generation platform launches, including automated dosing, integrated digital connectivity, and simplified circuit set-up, are improving usability and driving equipment upgrade cycles across ICUs.
- The aging global population and rising prevalence of comorbidities such as diabetes, hypertension, and cardiovascular disease are increasing the incidence of both acute kidney injury and chronic kidney disease requiring renal support in acute settings.
- Growing adoption of AI-integrated and remotely monitored CRRT platforms is improving treatment precision, reducing clinician burden, and supporting decentralized and portable delivery models across critical care and expanding healthcare infrastructure in emerging economies.
- The convergence of rising AKI and sepsis burden, ICU expansion, and continuous platform innovation is expected to sustain steady, high-single-digit growth in the market through 2034.
Key Companies in Continuous Renal Replacement Therapy (CRRT) Machines Market
The competitive landscape is led by the following active device manufacturers:
- Baxter
- Fresenius Medical Care AG
- NIKKISO CO., LTD
- B.Braun Melsungen AG
- Asahi Kasei Corporation
- Infomed SA
- Medtronic
- NxStage Medical, Inc.
- Medica S.p.A.
- SWS Hemodialysis Care Co.
Factors Contributing to the Growth of the Continuous Renal Replacement Therapy (CRRT) Machines Market
Market Drivers
Rising Global Burden of Acute Kidney Injury
The most fundamental driver of the CRRT Machines market is the persistently high global incidence of acute kidney injury among critically ill patients. The International Society of Nephrology estimates approximately 13.3 million cases of AKI occur annually worldwide, with an outsized share concentrated in emerging economies where an estimated 11.3 million cases arise each year. AKI frequently accompanies sepsis, major surgery, trauma, and multi-organ failure, and hemodynamically unstable patients are often unable to tolerate the rapid fluid and solute shifts associated with conventional intermittent hemodialysis. CRRT's gradual, continuous approach to fluid and solute removal makes it the preferred renal support modality in these settings, and as AKI incidence continues to rise alongside expanding critical-care capacity, demand for CRRT machines and their associated consumables grows correspondingly through 2034.
High Global Prevalence of Sepsis
Sepsis is a leading driver of ICU admissions and a major indication for continuous renal support. The Global Sepsis Alliance's recently updated estimates indicate that sepsis affects between 47 and 50 million individuals globally each year, and CRRT is widely used to manage the fluid overload, electrolyte disturbance, and inflammatory toxin burden associated with severe sepsis and septic shock. Global observance of World Sepsis Day, initiated by the Global Sepsis Alliance in 2012, has further raised clinical and public awareness of sepsis management, including the role of continuous renal replacement therapies. As sepsis incidence remains elevated worldwide and ICU protocols increasingly incorporate CRRT for hemodynamic stabilization, this driver is expected to sustain robust equipment and consumable demand across the forecast period.
Market Restraints
Despite steady momentum, the CRRT Machines market faces material constraints. CRRT can itself contribute to hemodynamic instability, fluid imbalance, and alteration of blood electrolyte levels, requiring careful clinical management and skilled nursing and physician oversight that can limit adoption in resource-constrained settings. The high capital cost of CRRT machines and the recurring cost of specialized consumables, including filters, catheters, dialysates, and replacement and anticoagulation solutions, create affordability barriers for smaller hospitals and healthcare systems in emerging economies. A shortage of critical-care nursing staff and clinicians trained in continuous renal support further constrains scale-up, while stringent regulatory compliance requirements across major markets lengthen product development and approval timelines. Reimbursement policies for CRRT procedures also vary considerably across geographies, and dependence on a limited number of established equipment and consumable suppliers concentrates supply risk. Together, these clinical, capital, workforce, and reimbursement barriers temper the pace of growth, even as the underlying drivers of rising AKI and sepsis burden, ICU expansion, and platform innovation remain firmly intact.
Continuous Renal Replacement Therapy (CRRT) Machines Market Segment Analysis
The Continuous Renal Replacement Therapy (CRRT) Machines by Product Type (Machines and Consumables), Modality (Slow Continuous Ultrafiltration (SCUF), Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodialysis (CVVHD), and Continuous Venovenous Hemodiafiltration (CVVHDF)), Patient (Adult and Pediatric), End-User (Hospitals, Dialysis Centres, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of World).
By Product Type
Dominant Subsegment: Machines.
Dominant: Machine ~ 54%
The machines segment accounted for 54% of the CRRT Machines market in 2025. Machines lead the product-type segmentation because CRRT systems represent the primary capital equipment investment for hospitals building or expanding critical-care renal support capacity, and each new or replacement ICU bed dedicated to continuous renal therapy requires a control unit and associated hardware. Manufacturers continue to compete on automation, integrated digital connectivity, and simplified circuit set-up, which drives replacement and upgrade cycles among hospitals seeking to standardize on next-generation platforms. While consumables, including filters, catheters, dialysates, and replacement solutions, generate the more frequent, recurring revenue associated with each treatment cycle and are growing quickly as CRRT procedure volumes rise, the substantial upfront cost and multi-year replacement cycle of machines secures the segment's leadership by revenue share across the forecast period.
By Modality
Dominant Subsegment: Continuous Venovenous Hemodiafiltration (CVVHDF).
Dominant: CVVHDF ~ 38%
The continuous venovenous hemodiafiltration (CVVHDF) segment accounted for 38% of the CRRT Machines market in 2025. CVVHDF is the leading modality because it combines diffusion and convection, enabling comprehensive clearance of both small and middle-molecular-weight solutes alongside precise fluid management, making it well suited to critically ill patients with complex metabolic imbalances, sepsis, and multi-organ dysfunction. Its operational flexibility and ability to be tailored to individual patient needs have driven growing clinician preference over single-mechanism modalities. Continuous venovenous hemofiltration (CVVH) remains widely used and continues to hold a meaningful revenue share given its established convective clearance profile, while continuous venovenous hemodialysis (CVVHD) is valued for its effectiveness in managing fluid overload through diffusive clearance. Slow continuous ultrafiltration (SCUF), used primarily for isolated fluid removal, holds the smallest share given its narrower clinical indication. Nonetheless, the comprehensive clearance profile and rising clinical preference for CVVHDF secure its leadership across the forecast period.
Continuous Renal Replacement Therapy (CRRT) Machines Market Region Analysis
Dominant Region: North America
Dominant: North America ~ 40% (Largest)
North America accounted for 40% of the global CRRT Machines market revenue in 2025, representing the highest regional market share globally. The region's dominance reflects a high prevalence of end-stage and acute renal conditions, a mature and well-established critical-care infrastructure, clear FDA regulatory pathways, and the concentrated presence of leading CRRT manufacturers. North America hosts an extensive network of hospital ICUs equipped for continuous renal support, and favorable reimbursement frameworks for acute-care dialysis procedures encourage hospitals to maintain adequate CRRT equipment inventories. Continued investment in next-generation platforms featuring AI-powered dosing algorithms and integrated electronic health record connectivity, combined with strong clinical awareness of CRRT's hemodynamic advantages over intermittent dialysis, anchors the region's continued leadership across the forecast period.
Fastest Growing Region: Asia-Pacific
Asia-Pacific is the fastest-growing region in the CRRT Machines market. The region's elevated CAGR is driven by the rapidly aging population, rising incidence of kidney disorders, and expanding critical-care and hospital infrastructure across China, Japan, India, South Korea, and Australia. China is expanding hospital ICU capacity and domestic device manufacturing, Japan continues to refine advanced renal-support protocols within its established dialysis ecosystem, and India is benefiting from rising healthcare investment and growing awareness of CRRT's advantages over conventional dialysis in critical-care settings. Government healthcare investment, expanding critically ill patient populations, and growing local manufacturing of CRRT machines and consumables are accelerating adoption across the region, positioning Asia-Pacific as the principal source of incremental growth over the forecast period.
Regional Commentary
North America
North America accounted for 40% of the global CRRT Machines market revenue in 2025. The United States dominates on the strength of its critical-care infrastructure, established reimbursement pathways for acute-care renal support, and the concentrated presence of leading manufacturers, while continued investment in AI-enabled and digitally connected CRRT platforms reinforces its leadership.
Europe
Europe is a large and technologically advanced regional market, supported by established regulatory frameworks, a strong base of critical-care research, and a concentrated presence of leading manufacturers headquartered in Germany and Switzerland. Continued platform innovation across Germany, France, the United Kingdom, Italy, and Spain reinforces the region's role in both diagnostic and therapeutic critical-care renal support.
Asia-Pacific
Asia-Pacific is the fastest-growing region, propelled by the rapidly aging population, rising kidney disorder incidence, and expanding hospital and ICU infrastructure across China, Japan, India, South Korea, and Australia. Growing local manufacturing capacity and healthcare investment are accelerating regional adoption of CRRT machines and consumables.
Rest of World
The Rest of World region, spanning Latin America, the Middle East, and Africa, is an emerging growth frontier. Expanding hospital and critical-care infrastructure, rising awareness of continuous renal support, and gradual alignment of regulatory frameworks with global standards are broadening access, while international partnerships support the build-out of regional critical-care capacity.
Continuous Renal Replacement Therapy (CRRT) Machines Market Competitive Landscape
The CRRT Machines market is classified as Moderately Fragmented. A group of large, diversified medical device manufacturers with established critical-care portfolios, including Baxter, Fresenius Medical Care AG, B.Braun Melsungen AG, and Medtronic, anchor the top tier through broad platform availability and global distribution networks, while specialized providers such as NIKKISO CO., LTD, Asahi Kasei Corporation, Infomed SA, NxStage Medical, Inc., Medica S.p.A., and SWS Hemodialysis Care Co. compete through regional manufacturing strength, focused product portfolios, and targeted geographic reach.
The competitive landscape can be evaluated across the following dimensions:
- Market concentration: Moderately fragmented, with diversified global leaders competing alongside specialized regional device manufacturers.
- Leading players: Baxter, Fresenius Medical Care AG, B.Braun Melsungen AG, and Medtronic anchor the top tier through broad critical-care portfolios and global reach.
- Geographic reach: Leading manufacturers operate global distribution and service networks essential for supporting ICU customers across major and emerging markets.
- Product portfolio strength: Top players offer integrated CRRT platforms spanning control units, disposable circuit sets, filters, and digital connectivity solutions.
- Technology and automation: Automated dosing, simplified pre-connected circuits, and integrated digital health connectivity are decisive competitive differentiators.
- Regional manufacturing strength: Specialized players such as NIKKISO, Asahi Kasei, and SWS Hemodialysis Care leverage regional manufacturing bases to serve Asia-Pacific hospital demand.
- Manufacturing capabilities: Precision fluid-management engineering, hemofilter membrane technology, and regulatory-compliant manufacturing are key competitive moats.
- Innovation focus: AI-enabled dosing algorithms, portable and decentralized CRRT platforms, and enhanced digital connectivity for ICU quality-improvement programs.
Continuous Renal Replacement Therapy (CRRT) Machines Market Recent Developmental Activities
In 2025-2026, Baxter continued the global rollout of its PrisMax continuous renal replacement therapy platform, including its TrueVue digital health connectivity solutions designed to support ICU quality-improvement programs. Strategic significance: Reinforces Baxter's leadership in automated, digitally connected CRRT platforms across hospital ICUs.
Continuous Renal Replacement Therapy (CRRT) Machines Market Segmentation
Continuous Renal Replacement Therapy (CRRT) Machines Market by Product Type
- Machines
- Consumables
Continuous Renal Replacement Therapy (CRRT) Machines Market by Modality
- Slow Continuous Ultrafiltration (SCUF)
- Continuous Venovenous Hemofiltration (CVVH)
- Continuous Venovenous Hemodialysis (CVVHD)
- Continuous Venovenous Hemodiafiltration (CVVHDF)
Continuous Renal Replacement Therapy (CRRT) Machines Market by Patient
- Adult
- Pediatric
Continuous Renal Replacement Therapy (CRRT) Machines Market by End User
- Hospitals
- Dialysis Centers
- Others
Continuous Renal Replacement Therapy (CRRT) Machines Market by Geography
- North America Continuous Renal Replacement Therapy (CRRT) Machines Market
- United States Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
- Canada Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
- Mexico Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
- Europe Continuous Renal Replacement Therapy (CRRT) Machines Market
- Germany Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
- United Kingdom Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
- France Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
- Italy Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
- Spain Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
- Rest of Europe Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
- Asia-Pacific Continuous Renal Replacement Therapy (CRRT) Machines Market
- China Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
- Japan Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
- India Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
- Australia Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
- South Korea Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
- Rest of Asia-Pacific Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
- Rest of the World (RoW) Continuous Renal Replacement Therapy (CRRT) Machines Market
- Middle East Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
- Africa Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
- South America Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
Key Takeaways from the Continuous Renal Replacement Therapy (CRRT) Machines Market Report Study
- Market size analysis for the current Continuous Renal Replacement Therapy (CRRT) Machines market size (2025), and market forecast for 9 years (2026 to 2034).
- Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures that happened over the last 3 years.
- Key companies dominating the global Continuous Renal Replacement Therapy (CRRT) Machines market.
- Various opportunities available for competitors in the Continuous Renal Replacement Therapy (CRRT) Machines market space.
- What are the top-performing segments in 2025? How will these segments perform in 2034?
- Which are the top-performing regions and countries in the current Continuous Renal Replacement Therapy (CRRT) Machines market scenario?
- Which are the regions and countries where companies should concentrate their opportunities for Continuous Renal Replacement Therapy (CRRT) Machines market growth in the future?
Target audience who can benefit from this Continuous Renal Replacement Therapy (CRRT) Machines market report study
- Continuous Renal Replacement Therapy (CRRT) Machines product providers
- Research organizations and consulting companies
- Continuous Renal Replacement Therapy (CRRT) Machines-related organizations, associations, forums, and other alliances
- Government and corporate offices
- Start-up companies, venture capitalists, and private equity firms
- Distributors and traders dealing in Continuous Renal Replacement Therapy (CRRT) Machines
- Various end-users who want to know more about the Continuous Renal Replacement Therapy (CRRT) Machines market and the latest technological developments in the Continuous Renal Replacement Therapy (CRRT) Machines market.
Frequently Asked Questions:
Q1. What is the growth rate of the Continuous Renal Replacement Therapy (CRRT) Machines market?
The Continuous Renal Replacement Therapy (CRRT) Machines market is projected to expand at a CAGR of 8.20% during the forecast period from 2026-2034.
Q2. What is the market size of the Continuous Renal Replacement Therapy (CRRT) Machines market?
The Continuous Renal Replacement Therapy (CRRT) Machines market is estimated at USD 1.25 billion in 2025 and is projected to reach USD 2.52 billion by 2034.
Q3. Which region dominates the Continuous Renal Replacement Therapy (CRRT) Machines market?
North America dominated the CRRT Machines market with a 40% share of global revenue in 2025, supported by a mature critical-care infrastructure, established reimbursement pathways, FDA regulatory clarity, and the concentrated presence of leading manufacturers. Asia-Pacific is the fastest-growing region over the forecast period.
Q4. What are the key drivers of the Continuous Renal Replacement Therapy (CRRT) Machines market?
The principal drivers are the rising global burden of acute kidney injury, with an estimated 13.3 million cases occurring annually worldwide; the high global prevalence of sepsis, affecting an estimated 47 to 50 million individuals each year; expanding ICU infrastructure and rising hospital admissions; continuous product development and platform innovation; and the aging global population's rising comorbidity burden.
Q5. Who are the major players in the Continuous Renal Replacement Therapy (CRRT) Machines market?
The major players include Baxter, Fresenius Medical Care AG, NIKKISO CO., LTD, B.Braun Melsungen AG, Asahi Kasei Corporation, Infomed SA, Medtronic, NxStage Medical, Inc., Medica S.p.A., and SWS Hemodialysis Care Co., among other active providers profiled in the Competitive Landscape section.
Table of Contents
1. Continuous Renal Replacement Therapy (CRRT) Machines Market Report Introduction
- 1.1 Scope of the Study
- 1.2 Market Segmentation
- 1.3 Market Assumptions
2. Continuous Renal Replacement Therapy (CRRT) Machines Market Executive Summary
- 2.1 Market at a Glance
3. Continuous Renal Replacement Therapy (CRRT) Machines Market Key Factors Analysis
- 3.1 Continuous Renal Replacement Therapy (CRRT) Machines Market Drivers
- 3.1.1 Rising Global Burden of Acute Kidney Injury
- 3.1.2 High Global Prevalence of Sepsis
- 3.1.3 Expanding ICU Infrastructure and Hospital Admissions
- 3.1.4 Continuous Product Development and Platform Innovation
- 3.2 Continuous Renal Replacement Therapy (CRRT) Machines Market Restraints and Challenges
- 3.2.1 Hemodynamic Instability and Electrolyte Imbalance Risk
- 3.2.2 High Capital and Consumable Costs
- 3.2.3 Regulatory, Workforce, and Reimbursement Complexity
- 3.3 Continuous Renal Replacement Therapy (CRRT) Machines Market Opportunities
- 3.3.1 AI-Enabled Dosing and Automation Scale-Up
- 3.3.2 Emerging-Market and Portable Platform Expansion
4. Impact Analysis: AI, Geopolitical, Trade, and Economic Developments
5. Regulatory Analysis
- 5.1 United States
- 5.2 Europe
- 5.3 Japan
- 5.4 China
6. Continuous Renal Replacement Therapy (CRRT) Machines Market Porter's Five Forces Analysis
- 6.1 Bargaining Power of Suppliers
- 6.2 Bargaining Power of Buyers
- 6.3 Threat of New Entrants
- 6.4 Threat of Substitutes
- 6.5 Competitive Rivalry
7. Continuous Renal Replacement Therapy (CRRT) Machines Market Assessment
- 7.1 By Product Type
- 7.1.1 Machines
- 7.1.2 Consumables
- 7.2 By Modality
- 7.2.1 Slow Continuous Ultrafiltration (SCUF)
- 7.2.2 Continuous Venovenous Hemofiltration (CVVH)
- 7.2.3 Continuous Venovenous Hemodialysis (CVVHD)
- 7.2.4 Continuous Venovenous Hemodiafiltration (CVVHDF)
- 7.3 By Patient
- 7.3.1 Adult
- 7.3.2 Pediatric
- 7.4 By End-User
- 7.4.1 Hospitals
- 7.4.2 Dialysis Centers
- 7.4.3 Others
- 7.5 By Geography
- 7.5.1 North America
- 7.5.1.1 United States Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
- 7.5.1.2 Canada Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
- 7.5.1.3 Mexico Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
- 7.5.2 Europe
- 7.5.2.1 Germany Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
- 7.5.2.2 United Kingdom Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
- 7.5.2.3 France Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
- 7.5.2.4 Italy Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
- 7.5.2.5 Spain Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
- 7.5.2.6 Rest of Europe Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
- 7.5.3 Asia-Pacific
- 7.5.3.1 China Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
- 7.5.3.2 Japan Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
- 7.5.3.3 India Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
- 7.5.3.4 Australia Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
- 7.5.3.5 South Korea Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
- 7.5.3.6 Rest of Asia-Pacific Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
- 7.5.4 Rest of World
- 7.5.4.1 Middle East Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
- 7.5.4.2 Africa Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
- 7.5.4.3 South America Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
- 7.5.1 North America
8. Continuous Renal Replacement Therapy (CRRT) Machines Market Competitive Landscape
- 8.1 Market Concentration and Structure
- 8.2 Competitive Positioning and Market Share Analysis (Premium Offering)
9. Continuous Renal Replacement Therapy (CRRT) Machines Market Startup Funding and Investment Trends
10. Continuous Renal Replacement Therapy (CRRT) Machines Market Company and Product Profiles
- 10.1 Baxter
- 10.1.1 Company Overview
- 10.1.2 Company Snapshot
- 10.1.3 Financial Overview
- 10.1.4 Service Portfolio
- 10.1.5 Strategic Initiatives / Entropy
- 10.2 Fresenius Medical Care AG
- 10.2.1 Company Overview
- 10.2.2 Company Snapshot
- 10.2.3 Financial Overview
- 10.2.4 Product Portfolio
- 10.2.5 Strategic Initiatives / Entropy
- 10.3 NIKKISO CO., LTD
- 10.3.1 Company Overview
- 10.3.2 Company Snapshot
- 10.3.3 Financial Overview
- 10.3.4 Product Portfolio
- 10.3.5 Strategic Initiatives / Entropy
- 10.4 B.Braun Melsungen AG
- 10.4.1 Company Overview
- 10.4.2 Company Snapshot
- 10.4.3 Financial Overview
- 10.4.4 Product Portfolio
- 10.4.5 Strategic Initiatives / Entropy
- 10.5 Asahi Kasei Corporation
- 10.5.1 Company Overview
- 10.5.2 Company Snapshot
- 10.5.3 Financial Overview
- 10.5.4 Product Portfolio
- 10.5.5 Strategic Initiatives / Entropy
- 10.6 Infomed SA
- 10.6.1 Company Overview
- 10.6.2 Company Snapshot
- 10.6.3 Financial Overview
- 10.6.4 Product Portfolio
- 10.6.5 Strategic Initiatives / Entropy
- 10.7 Medtronic
- 10.7.1 Company Overview
- 10.7.2 Company Snapshot
- 10.7.3 Financial Overview
- 10.7.4 Product Portfolio
- 10.7.5 Strategic Initiatives / Entropy
- 10.8 NxStage Medical, Inc.
- 10.8.1 Company Overview
- 10.8.2 Company Snapshot
- 10.8.3 Financial Overview
- 10.8.4 Product Portfolio
- 10.8.5 Strategic Initiatives / Entropy
- 10.9 Medica S.p.A.
- 10.9.1 Company Overview
- 10.9.2 Company Snapshot
- 10.9.3 Financial Overview
- 10.9.4 Product Portfolio
- 10.9.5 Strategic Initiatives / Entropy
- 10.10 SWS Hemodialysis Care Co.
- 10.10.1 Company Overview
- 10.10.2 Company Snapshot
- 10.10.3 Financial Overview
- 10.10.4 Product Portfolio
- 10.10.5 Strategic Initiatives / Entropy
For illustrative purposes, only the top 10 companies are listed in the Table of Contents. The report may include analysis and references to additional companies where relevant to the market assessment.
